Health Catalyst (HCAT)
(Delayed Data from NSDQ)
$7.15 USD
+0.10 (1.42%)
Updated Aug 21, 2024 04:00 PM ET
After-Market: $7.16 +0.01 (0.14%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth D Momentum C VGM
Income Statements
Fiscal Year end for Health Catalyst, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 296 | 276 | 242 | 189 | 155 |
Cost Of Goods | 164 | 143 | 124 | 98 | 75 |
Gross Profit | 132 | 133 | 118 | 91 | 80 |
Selling & Adminstrative & Depr. & Amort Expenses | 259 | 273 | 261 | 187 | 134 |
Income After Depreciation & Amortization | -127 | -140 | -144 | -96 | -55 |
Non-Operating Income | 0 | 0 | 0 | -9 | -2 |
Interest Expense | -9 | 2 | 16 | 12 | 3 |
Pretax Income | -118 | -142 | -160 | -116 | -60 |
Income Taxes | 0 | -4 | -7 | -1 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -118 | -137 | -153 | -115 | -60 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -118 | -137 | -153 | -115 | -60 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -83 | -90 | -94 | -69 | -45 |
Depreciation & Amortization (Cash Flow) | 44 | 50 | 49 | 27 | 10 |
Income After Depreciation & Amortization | -127 | -140 | -144 | -96 | -55 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 56.42 | 54.08 | 47.50 | 39.54 | 18.74 |
Diluted EPS Before Non-Recurring Items | -0.84 | -1.59 | -1.82 | -1.64 | -1.42 |
Diluted Net EPS (GAAP) | -2.09 | -2.63 | -3.23 | -2.91 | -12.86 |
Fiscal Year end for Health Catalyst, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 75.90 | 74.72 | 75.08 | 73.77 | 73.21 |
Cost Of Goods | 40.06 | 38.52 | 44.58 | 41.79 | 39.44 |
Gross Profit | 35.84 | 36.21 | 30.51 | 31.99 | 33.78 |
SG&A, R&D, and Dept/Amort Expenses | 51.65 | 59.02 | 63.29 | 56.57 | 68.40 |
Income After SG&A, R&D, and Dept/Amort Expenses | -15.81 | -22.81 | -32.78 | -24.58 | -34.62 |
Non-Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | -2.36 | -2.34 | -2.62 | -2.61 | -2.09 |
Pretax Income | -13.45 | -20.47 | -30.17 | -21.97 | -32.53 |
Income Taxes | 0.07 | 0.11 | 0.14 | 0.06 | 0.09 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -13.52 | -20.59 | -30.31 | -22.03 | -32.61 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -13.52 | -20.59 | -30.31 | -22.03 | -32.61 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 59.30 | 58.59 | 57.48 | 56.71 | 55.98 |
Diluted EPS Before Non-Recurring Items | -0.03 | -0.14 | -0.21 | -0.22 | -0.21 |
Diluted Net EPS (GAAP) | -0.23 | -0.35 | -0.52 | -0.39 | -0.58 |